Imaging Diagnostic and Pathology in the Management of Oncological-Patients

Personalized medicine is one of the main objectives of both basic and translational cancer research. Nevertheless, it has become clear that the creation of personalized therapeutic protocols requires synergistic, transdisciplinary competencies. Indeed, novel approved therapies rarely take into account both the interindividual variability and the aptitude of cancer cells to undergo those genetic and molecular adaptation involved in the drug resistance phenomenon. In spite of recent and promising biomedical and biomarker discoveries, individually tailored medical care is still far from reality, and molecules which are output by preclinical trials are very rarely translatable to evaluation for the diagnostic or therapeutical potential.